Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z7CZ
|
||||
Former ID |
DIB020198
|
||||
Drug Name |
L-CCG-I
|
||||
Synonyms |
3,4-Cyclopropylglutamate; CCPG; L-2-(Carboxypropyl)glycine; L-CCG-I
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [538846] | ||
Structure |
Download2D MOL |
||||
Formula |
C6H9NO4
|
||||
InChI |
InChI=1S/C6H9NO4/c7-4(6(10)11)2-1-3(2)5(8)9/h2-4H,1,7H2,(H,8,9)(H,10,11)/t2-,3-,4-/m0/s1
|
||||
InChIKey |
GZOVEPYOCJWRFC-HZLVTQRSSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor 8 | Target Info | Agonist | [525476] | |
Metabotropic glutamate receptor 2 | Target Info | Agonist | [525619] | ||
Metabotropic glutamate receptor3 | Target Info | Agonist | [525619] | ||
Metabotropic glutamate receptor 7 | Target Info | Agonist | [525945] | ||
Metabotropicglutamate receptor 1 | Target Info | Agonist | [525911] | ||
Metabotropic glutamate receptor 5 | Target Info | Agonist | [525911] | ||
Metabotropic glutamate receptor 4 | Target Info | Agonist | [526752] | ||
mGlu6 receptor | Target Info | Agonist | [534761] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Glutamatergic synapsehsa04080:Neuroactive ligand-receptor interaction | |||||
Glutamatergic synapse | |||||
Cocaine addictionhsa04080:Neuroactive ligand-receptor interaction | |||||
Glutamatergic synapsehsa04020:Calcium signaling pathway | |||||
FoxO signaling pathway | |||||
Gap junction | |||||
Long-term potentiation | |||||
Retrograde endocannabinoid signaling | |||||
Long-term depression | |||||
Estrogen signaling pathwayhsa04020:Calcium signaling pathway | |||||
Huntington's diseasehsa04080:Neuroactive ligand-receptor interaction | |||||
Taste transduction | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Ionotropic glutamate receptor pathway | |||||
Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathwayP00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathway | |||||
Metabotropic glutamate receptor group I pathway | |||||
Endogenous cannabinoid signalingP00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Endogenous cannabinoid signalingP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
WikiPathways | GPCRs, Class C Metabotropic glutamate, pheromone | ||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP501:GPCRs, Class C Metabotropic glutamate, pheromone | |||||
GPCR downstream signalingWP501:GPCRs, Class C Metabotropic glutamate, pheromone | |||||
GPCR downstream signalingWP666:Hypothetical Network for Drug Addiction | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCRs, OtherWP666:Hypothetical Network for Drug Addiction | |||||
References | |||||
Ref 525476 | Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Brain Res Mol Brain Res. 1999 Apr 20;67(2):201-10. | ||||
Ref 525619 | [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells. Neuropharmacology. 1999 Oct;38(10):1519-29. | ||||
Ref 525911 | Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. J Neurochem. 2000 Dec;75(6):2590-601. | ||||
Ref 525945 | Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):546-54. | ||||
Ref 526752 | Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. Br J Pharmacol. 1992 Oct;107(2):539-43. | ||||
Ref 534761 | Comparative effect of L-CCG-I, DCG-IV and gamma-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes. Neuropharmacology. 1998 Aug;37(8):1043-51. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.